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  The purpose of this study was to determine the prevalence of bovine leukemia virus (BLV) 
in Khorasan Razavi and Khorasan Shomali provinces which are the main provinces located in 
the northeast of Iran. Total number of 429 blood samples were collected from industrial dairy 
herds. The samples were categorized based on province, age (2-3, 4-6, and 7-10 years old), 
calving (≤ 2, 3-5, and > 5) and herd size (≤ 100, 101-250, and > 250) and examined by indirect 
ELISA. The results of this study showed that 109 (25.4%) out of 429 serum samples were BLV 
seropositive. The BLV prevalence among cattle of dairy herds of Khorasan Razavi and Khorasan 
Shomali provinces were 29.8% and 1.5%, respectively. The results showed that the number of 
seropositive animals was increased significantly with the age (p < 0.05). The infection rate in 
animals 2-3, 4-6 and 7-10 years old were 12.1%, 26.7% and 45.6%, respectively. It was shown 
that BLV prevalence according to calving ≤ 2, 3-5 and > 5 was 15.5%, 33.0% and 42.9%, respectively, 
with a significant difference between calving ≤ 2 and > 5 (p < 0.001). The prevalence of BLV 
among herd size of ≤ 100, 101-250 and > 250 was 19.7%, 14.3% and 42.1%, respectively, which 
was significantly higher in herds with more than 250 cattle (p < 0.05). This study revealed that 
BLV  infection  in  dairy  herds  of  northeast  of  Iran  was  influenced  by  geographical  location 
(province), age, calving and herd size. 
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( ׌واگ زو֩ول سور׌و اب ׌گدولآ ׌ناوارف ׌سررب BLV نار׌ا ׌قرش لامش رد )  
 هد׌֩چ  
 عو׌ش ن׌׌عت هعلاطم ن׌ا زا فده سور׌و   زوکول   ׌واگ    عومجم رد .دوب نار׌ا قرش لامش رد عقاو ׌لصا ׌اهناتسا ،׌وضر ناسارخ و ׌لامش ناسارخ رد 924    ׌اه ׌رادواگ زا نوخ هنومن
من .دش ׌روآ عمج ׌تعنص ׌ر׌ش ( نس ،ناتسا ساسا رب اه هنو 3 - 2  ، 6 - 9  ، 01 - 7   ( ش׌از ،)لاس 2   ≥  ، 5 - 3  ، 5   <  و ) ( ׌رادواگ ت׌عمج 011   ≥  ، 251 - 010  ، 251   <  شور هب و هدش ׌دنب هتسد )
 هک داد ناشن هعلاطم ن׌ا ج׌اتن .دنتفرگ رارق ش׌امزآ دروم م׌قتسم ر׌غ ׌از׌لاا 014   ( 9 / 25    زا )دصرد 924    ׌ارب مرس هنومن سور׌و   تسا تبثم  عو׌ش . سور׌و ن׌ا    ناسارخ ׌ر׌ش ׌اه ׌رادواگ نا׌م
 ب׌ترت هب ׌لامش ناسارخ و ׌وضر 8 / 24    و 5 / 0   ( دبا׌ ׌م ش׌ازفا نس نتفر لااب اب تبثم تاناو׌ح دادعت هک دهد׌م ناشن ج׌اتن .دوب دصرد 15 / 1   >   p  تاناو׌ح رد تنوفع ناز׌م .) 3 - 2  ، 6 - 9    و 01 - 7  
 ب׌ترت هب لاس 0 / 02  ، 7 / 26    و 6 / 95   دوب دصرد  عو׌ش هک داد ناشن ن׌نچمه هعلاطم ن׌ا ج׌اتن . سور׌و ن׌ا    ش׌از ساسا رب 2   ≥  ، 5 - 3    و 5   <    ب׌ترت هب 5 / 05  ، 1 / 33    و 4 / 92    لباق فلاتخا اب ؛دصرد
 ׌اه ش׌از نا׌م هجوت 2   ≥    و 5   <   تسا ،   ( 110 / 1   >   p  عو׌ش .) سور׌و ن׌ا    ت׌عمج اب ׌اه هلگ نا׌م 011   ≥  ، 251 - 010    و 251   <    ب׌ترت هب 7 / 04  ، 3 / 09   و   0 / 92    اب ׌اه ׌رادواگ رد و دوب دصرد
 زا رتلااب ت׌عمج 251   ( دبا׌ ׌م ش׌ازفا ׌هجوت لباق ناز׌م هب واگ 15 / 1   >   p  تنوفع هک داد ناشن هعلاطم ن׌ا .) سور׌و   زوکول   ׌واگ    ه׌حان ر׌ثأت تحت نار׌ا قرش لامش ׌ر׌ش ׌اه ׌رادواگ رد
 ׌م ׌رادواگ ت׌عمج و ش׌از دادعت ،نس ،)ناتسا( ׌׌ا׌فارغج .دشاب  
:׌د׌ل֩ ׌اه هژاو   ׌از׌لاا   م׌قتسم ر׌غ ،   نار׌ا ،   عو׌ش ،   ׌ر׌ش واگ ،   ׌واگ زوکول سور׌و  
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Introduction 
 
Bovine  leukemia  virus  (BLV),  a  lymphotropic  retro-
virus structurally related to human T-cell leukemia virus 
type 1, is the causative agent of enzootic bovine leukosis 
(EBL), a neoplasm of lymphatic tissue in bovine species.1 
There  are  three  pathological  forms  of  the  disease: 
asymptomatic  course,  persistent  lymphocytosis  (PL)  and 
lymphosarcoma.2  The  vast  majority  of  infected  animals 
remain healthy with no outward signs of infection and no 
apparent  negative  economic  effects,  but  approximately 
29.0% of BLV carriers develop PL and less than 5.0% of 
BLV-infected  cattle  develop  lymphosarcoma.3  Naturally, 
the disease occurs only in cattle but experimentally BLV 
can easily infect sheep which leads to development of B-cell 
lymphosarcomas at higher frequencies and after a shorter 
latent period than cattle.4 There is no virus in bloodstream 
but provirus can be integrated into genome of lymphocytes 
and tumor cells. Hence, these proviruses are found in cellular 
fraction of various body fluids which allow transmission 
via  milk,  congenital  transmission  and  most  commonly, 
iatrogenic,  and  horizontal  transmission  of  the  disease.5,6 
Infection with BLV has a worldwide distribution,7 and is 
listed by World Organization for Animal Health (OIE) as a 
disease of importance to international trade.5 Some European 
Union  (EU)  member  states  and  Australia  included  the 
disease in the national eradication program and several of 
which have eradicated the disease.8,9 Because of the lack of 
vaccine  and  vaccination,  detection  of  the  BLV  specific 
antibody in milk or serum could be a good indicator of the 
disease  and  can  be  exploited  as  a  practical  method  for 
disease screening.5,10 Envelop glycoprotein gp51 and viral 
capsid protein p24 specific antibodies can be found in milk 
and blood about three weeks after infection.5 Enzyme linked 
immunosorbent assay (ELISA) and agar gel immunodiffusion 
(AGID) tests are approved by OIE for trading purposes.5 
ELISA is a rapid method and has a higher sensitivity than 
AGID and it has been used as a screening test to identify 
infected  dairy  herds  in  regional  EBL  eradication 
programs.9,11 Prevalence studies on BLV infection has not 
been conducted in the northeastern of Iran. The objective 
of the present study was to estimate the prevalence of BLV 
in Khorasan Razavi and Khorasan Shomali provinces which 
are the main provinces located in the northeast of Iran. 
 
Materials and methods 
 
Study area.  Khorasan Razavi and Khorasan Shomali 
provinces are the main provinces located in the northeast 
of Iran. These provinces have a mountainous area of more 
than  155000  km2.  At  the  lower  parts,  fertile  plants  are 
present which make the suitable condition for development 
of animal and agricultural husbandry. These provinces are 
located in north temperature zone and the climate is semi- 
arid with moderate summers and cold winters.  
  Population and sampling. To date, no comprehensive 
study  regarding  the  prevalence  of  the  disease  in  the 
northeast of Iran has been  performed, so  the  estimated 
prevalence is considered as 50.0%. Therefore, the sample 
size  required  for  our  study  with  the  desired  absolute 
precision of 95% and an expected prevalence of 50% was 
calculated using the following formula:12 
n = 
1.962Pexp ( 1 – Pexp) 
d2 
where n is the required sample size, Pexp is the expected 
prevalence, d is the desired absolute precision. 
The  number  of  the  serum  samples  required  by  the 
above formula was 384, however,  the ELISA test in the 
present  study  was  conducted  on  429  serum  samples. 
During summer 2009, blood samples (n = 429) were taken 
from  20  industrial  dairy  herds  of  Khorasan  Razavi  and 
Khorasan Shomali provinces with total number of 3183 
dairy cattle. Seventeen herds from nine cities of Khorasan 
Razavi  and  three  herds  from  three  cities  of  Khorasan 
Shomali  were  selected  according  to  a  random  cluster 
sampling program. The range of dairy cattle in selected herds 
of Khorasan Razavi and Khorasan Shomali were 493 and 
137, respectively. The samples were categorized based on 
the provinces (Khorasan Razavi and Khorasan Shomali), 
age (2-3, 4-6, 7-10 years old), calving (≤ 2, 3-5, > 5) and 
herd size (≤ 100, 101-250, > 250). Blood samples were 
collected  in  vacuum  tubes  (Shandong  Weigao  Group 
Medical Polymer Co., Weihai, China) and were put on ice 
and transferred to laboratory. Samples were centrifuged at 
3000 g for 15 min at 20 ˚C in laboratory and then the sera 
were  stored  at  –20  ˚C  before  analysis  by  Svanova  BLV 
gp51-Ab ELISA kit (Svanova Biotech, Uppsala, Sweden). 
Serological  examination.  The  Svanova  BLV  gp51-Ab 
ELISA,  an  indirect  ELISA,  was  used  for  detection  of 
antibodies  against  BLV  in  serum  samples  according  to 
manufacturer protocol. The sensitivity (Se) and speciﬁcity 
(Sp) of the ELISA test were 100 and 99.4%, respectively. 
Positive,  negative  and  blank  controls  and  the  samples 
were  run  in  parallel.  Optical  density  (OD)  values  were 
determined  at  450  nm  with  an  ELx800  absorbance 
microplate reader (BioTek Instruments, Winooski, USA). 
Before interpretation of the results, all OD values in wells 
coated  with  BLV  gp51  viral  antigen  were  corrected  by 
subtracting the ODs of negative control from the samples 
ODs  (ODcorrected  =  ODsample  –  ODcontrol).  Percent  positivity 
values (PP values) were evaluated. All corrected OD values 
for the test samples and the negative control were related 
to the corrected OD values of the positive control as follows:  
 
PP = 
Test sample or negative control (ODcorrected) 
× 100 
Positive control (ODcorrected) 
 
The  PP  value  equivalent  or  greater  than  10  were 
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Statistical analysis. Statistical analyses were performed 
using  SPSS  (Version  12;  SPSS  Inc.,  Chicago,  USA).  The 
Rogan  and  Gladen’s  correction  of  apparent  prevalence 
were used for estimation of the true prevalence of the 
disease  which  was  equated  as  below.  Chi-square 
statistical method was used for data analysis. Odds ratios 
and 95 percent confidence intervals were calculated for 
cattle groups. 
True prevalence = 
Apparent prevalence + Sp – 1 
Se + Sp – 1 
Results 
 
It was demonstrated that 109 (apparent prevalence 
= 25.4%) out of 429 serum samples were BLV seropositive. 
However, the true prevalence of BLV antibody-positive 
was 24.6%. The prevalence was ranged from 0 to 93.3% 
within the herds. The BLV prevalence among cattle of 
dairy herds of Khorasan Razavi and Khorasan Shomali 
provinces was 29.8% and 1.5%, respectively (Table 1). 
Herd  level  prevalence  for  Khorasan  Razavi  and 
Khorasan Shomali was 64.7% and 33.3%, respectively. 
The results of our study showed that the number of 
seropositive animals was increased significantly with age 
(p < 0.05). The infection rate in animals 2-3, 4-6 and 7-10 
years  old  were  12.1%,  26.7%  and  45.6%,  respectively 
(Table 1). The estimated odds ratio (OR) for the risk of 
BLV infection in cattle with 7-10 years old vs. cattle with 
2-3 and 4-6 years were 6.0 (p < 0.05, 95.5% CI = 3.0-11.8) 
and 2.3 (p < 0.05, 95.0% CI = 1.3-3.9), respectively (Table 2). 
It was shown that BLV prevalence according to calving 
≤ 2, 3-5, and > 5 was 15.5%, 33.0% and 42.9%, respectively 
(Table  1).  There  was  a  significant  difference  between 
calving > 5 and ≤ 2 (OR = 4.0, p < 0.001, 95.0% CI = 1.8-8.7) 
and calving 3-5 and ≤ 2 (OR = 2.6, p < 0.001, 95.0% CI = 
1.6-4.3), (Table 2). We have found that calving ≤ 2 and > 5 
had the lowest and the highest prevalence, respectively. 
Prevalence of BLV among herd size of ≤ 100, 101-250 
and > 250 was 19.7%, 14.3% and 42.1%, respectively (Table 1). 
The prevalence was significantly higher in herds with more 
than 250 cattle in comparison with herds with 101-250 
cattle (OR = 4.5, p < 0.001, 9.0% CI = 1.4-4.4), (Table 2). 
 
 
 
 
   
 
 
 
 
 
 
 
 
Discussion 
 
Previous studies showed prevalence of BLV infection in 
several cities in Iran.13-17 However, this is the first study of 
prevalence of BLV infection in northeastern provinces of 
Iran.  Previous  studies  from  other  regions  of  Iran  have 
reported prevalence of 3.0% in cattle in Central province,13 
5.7% in Chaharmahal and Bakhtyari province16 and 22.3% 
in Tehran province.17 This study that was performed on 
429 serum samples taken from dairy herds of Khorasan 
Razavi  and  Khorasan  Shomali  provinces  showed  a  true 
BLV prevalence of 24.6% (Apparent prevalence = 25.4%). 
In this study, the percentage of dairy herds that had at 
least one BLV-positive cattle was 65.0%. The ELISA test is 
more sensitive than AGID, however, both tests have high 
sensitivity and specificity and OIE has introduced them as 
the  standard  tests  for  sero-epidemiological  studies.5 
According  to  previous  surveys  and  the  present  study,  it 
could  be  concluded  that  since  entrance  of  the  high 
productive breeds to Iran, the prevalence of BLV infection 
is  growing.  This  increasing  BLV  prevalence  has  been  a 
result of lack of planning and management in control and 
eradication programs at the national levels. 
We found that the BLV prevalence among dairy cattle 
of Khorasan Razavi and Khorasan Shomali provinces was 
29.8% and 1.5%, respectively. There are reports of different 
BLV  prevalence  from  various  geographical  regions  or 
provinces of a country. Scott et al. reported a significantly 
more BLV-seropositive cows (61.0%) in Manitoba compared 
with  Saskatchewan  (37.0%),  New  Brunswick  (29.0%), 
Nova Scotia (16.0%) and Prince Edward Island (17.0%).18 
In  studies  that  have  been  made  so  far,  different  results 
were related to different time of survey, the type of test 
used and the different geographical regions.14,16 Therefore, 
different  prevalence  between  these  two  provinces  could 
be  expected  based  on  the  different  geographical  regions 
and different management practices and risk  factors. One 
of the major reasons in different and significant prevalence 
between Khorasan Shomali and Khorasan Razavi could be 
related to low population herds of Khorasan Shomali since 
we found that herd size  was a major  risk factor in our 
present and previous studies.19  
The results of  our study showed  that the number  of 
seropositive animals was increased significantly with the 
age,  calving  and  herd  size.  An  increase  of  BLV  sero-
prevalence with age has been reported in many studies.20,21 
Table  1. Prevalence of  bovine  leukemia virus among province, 
age, calving and herd size groups. 
Parameters  Positive (%) Negative (%)  Total 
Province    Khorasan Razavi   108 (29.8)   254 (70.2)  362 
Khorasan Shomali      1 (1.5)     66 (98.5)  67 
Age 
2-3     17 (12.1)  123 (87.9)  140 
4-6     56 (26.7)  154 (73.3)  210 
7-10     36 (45.6)    43 (54.4)  79 
Calving 
≤ 2    32 (15.5)  174 (84.5)  206 
3-5    62 (33.0)  126 (67.0)  188 
> 5    15 (42.9)    20 (57.1)  35 
Herd size 
≤ 100    39 (19.7)  159 (80.3)  198 
101-250    14 (14.3)    84 (85.7)  98 
> 250    56 (42.1)    77 (57.9)  133 
 
Table 2. Odds ratio values among different cattle groups.  
Comparative Parameters  OR  (95.0% CI)   p value 
7-10 years old  vs.  2-3 years old  6.05 (3.0-11.8)  p  < 0.001 
4-6 years old  2.30 (1.3-3.9)  p  < 0.01 
4-6 years old  vs.  2-3 years old  2.63 (1.4-4.7)  p  < 0.001 
Calving 3-5  vs.  Calving ≤ 2  2.67 (1.6-4.3)  p  < 0.001 
Calving > 5  vs.  Calving ≤ 2  4.07 (1.8-8.7)  p  < 0.001 
Herd size of > 250  vs.  101-250  4.54 (1.4-4.4)  p  < 0.001 
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The  longer  lifespan  results  in  a  longer  period  of  BLV 
exposure,  which  likely  leads  to  a  higher  prevalence  of 
BLV infection among dairy cattle.6,16  
Our  results  showed  that  the  BLV  prevalence  was 
significantly higher  in herds with  more  than  250 cattle. 
Intensive  dairy  production  in  dairy  herds  of  Khorasan 
Razavi  and  Khorasan  Shomali  provinces  is  based  on  a 
loose  housing  system  which  results  in  an  increased 
physical  contact  among  cattle  and  could  be  a  primary 
cause of BLV transmission.22 In a recent study, Kobayashi 
et  al.  showed  that  a  loose  housing  system  was  a  BLV 
transmission  risk  factor.23  Therefore,  this  significantly 
higher BLV prevalence in dairy herds with more than 250 
cattle which are primary located in Khorasan Razavi could 
be an  effect of higher  density in herds. In  our  previous 
study which was performed on bulk tank samples of dairy 
herds in Mashhad area, the capital city in Khorasan Razavi 
province, we found a significant and positive correlation 
between  herd  size  and  bulk  tank  milk  antibody  level,19 
which is consistent with the results of the present study.  
This  study  showed  a  prevalence  of  BLV  infection 
among  dairy  herds  in  Khorasan  Razavi  and  Khorasan 
Shomali. One of the important risk factors which should be 
considered for control and prevention of the disease is the 
effect  of  different  management  practices  among  the 
studied  dairy  herds.  Regarding  housing  condition,  some 
studies showed that a loose housing system was positively 
associated  with  seroprevalence  compared  with  a  tied 
housing  system.22  Dairy  herds  of  this  study  used  loose 
housing  system  which  could  increase  the  chances  of 
contact between uninfected and infected cattle and it could 
be a risk factor that caused BLV prevalence. 
As we observed dehorning was a daily practice in herd 
management  of  these  dairy  herds  and  since  dehorning 
apparatus was not disinfected during dehorning practice 
so it could be accounted as a risk factor for BLV trans-
mission among calves.24 Using common injection  needle 
during  vaccination  was  also  a  regular  procedure  in 
vaccination of the herds. However, reportedly, the quantity 
of infected lymphocytes  passed  during  common  needle 
injection is not enough to induce BLV infection.25 In this 
study, cows were regularly examined with common sleeves 
during pregnancy diagnosis, reproductive examination and 
artificial  insemination.  Blood  contaminated  sleeves  may 
transfer the infection between individual cows which could 
be accounted for BLV transmission in these herds. 26,27 
Another possible method of BLV transmission within 
the herds can be through hematophagous insects,28 and 
due  to  its  presence  in  the  studied  herds  especially  at 
summer season, we should consider it as an important risk 
factor associated with the prevalence of infection. 
It  has  been  shown  that  milk  and  colostrum  from 
infected  cattle  contain  BLV  infected  cells.29  However,  all 
BLV  positive  cattle  do  not  produce  infected  milk  at  all 
times.30 Since colostrum contains BLV antibodies, ingestion  
  of  colostrum  from  infected  cows  reduces  the  risk  of 
infection during the weaning period in calves.31 However, 
it has been reported that feeding of infected bulk milk can 
cause infection in neonatal calves especially from healthy 
dams.32 It was shown that BLV transmission rates in calves 
by  6-12  months  of  age  can  be  related  to  milk  born 
infection at approximately 6.0-16.0% in dairy herds.33 In 
dairy  herds  of  Khorasan  Razavi  and  Khorasan  Shomali, 
after calves get colostrum from their dams, they are fed by 
pooled  milk  which  can  transmit  the  BLV  from  infected 
cattle to calves. This common practice of feeding bulk milk 
to calves, unprotected by maternal antibody, is likely to be 
a major factor for the transmission of BLV infection in our 
study.27,34 Colostrum feeding could be an effective way for 
reducing the infection in dairy herds. Dairy herds of the 
present study should be provided by the best conditions 
for the treatment of pooled colostrum, such as heating and 
freezing on the herd, and bulk milk from uninfected cows 
or milk replacement should be fed to calves. Changing or 
washing sleeves between each rectal palpation should be 
considered for prevention of infection transmission. 
In conclusion, we showed for the first time prevalence 
of BLV in dairy herds of Khorasan Razavi and Khorasan 
Shomali provinces of Iran which are the major poles of 
dairy  production  in  northeast  of  Iran.  In  addition, 
estimated odds ratio revealed a significantly higher risk of 
BLV infection which was increased by herd size, age and 
calving. We found the same effect of age and calving on 
BLV prevalence, therefore, we should consider the effect of 
calving on BLV prevalence as an effect of higher age and 
exposure of dams to BLV. Regarding the observed prevalence 
and  economic  losses  associated  with  BLV  infection, 
prevention and control programs should be implemented. 
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